Fonar Corporation logo

Fonar Corporation (FONR)

Market Closed
5 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
19. 09
0
0%
$
117.76M Market Cap
9.12 P/E Ratio
- Div Yield
935,991 Volume
0 Eps
$ 19.09
Previous Close
Add Transaction
Day Range
19.09 19.09
Year Range
13.62 19.16
Want to track FONR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FONR closed Friday higher at $19.09, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, FONR stock gained 2.8556%.
FONR pays dividends to its shareholders, with the most recent payment made on Mar 30, 1999. The next estimated payment will be in 30 Mar 1999 on Mar 30, 1999 for a total of $0.0076.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.2142%, based on the last three reports.
Fonar Corporation has completed 2 stock splits, with the recent split occurring on Apr 17, 2007.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

FONR Chart

People also search for

Fennec Pharmaceuticals Inc.
$ 10.5
+0.5747%
CV
CapsoVision, Inc.
$ 6.71
+5.0078%
Amarin Corporation plc Sponsored ADR
$ 13.94
-1.6925%
IRD
Opus Genetics Inc.
$ 3.27
-0.3049%
Greenwich LifeSciences Inc.
$ 16.32
-14.1504%
FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit

FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit

FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.

Zacks | 8 months ago
FONR Stock Rises Following Q3 Earnings on Higher Net Income

FONR Stock Rises Following Q3 Earnings on Higher Net Income

FONAR Corporation's Q3 fiscal 2025 results show higher net income and revenue growth, driven by record MRI scan volumes and strong performance of its HMCA unit.

Zacks | 1 year ago
FONR Stock Declines After Q2 Earnings, Revenue and Net Income Fall

FONR Stock Declines After Q2 Earnings, Revenue and Net Income Fall

FONAR's second-quarter fiscal 2025 revenues and net income decline. Higher costs and lower scan volumes weigh on results.

Zacks | 1 year ago

Fonar Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
LAM
Lakewood Asset Management LLC Lakewood Asset Management LLC
19,057 $307,702.47 $363,798.13 $56,095.66 18.23%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
350 $5,243 $6,681.5 $1,438.5 27.44%
PLC
Peapod Lane Capital LLC Peapod Lane Capital LLC
113,662 $1.75M $2.17M $419,466.2 23.96%
GLF
Groupe La Francaise Groupe La Francaise
118,800 $2.2M $2.27M $62,964 2.86%
Bernard Wealth Management Corp
Bernard Wealth Management Corp Bernard Wealth Management Corp
1 $15.14 $19.09 $3.95 26.09%

Fonar Corporation (FONR) FAQ

What is the stock price today?

The current price is $19.09.

On which exchange is it traded?

Fonar Corporation is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is FONR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 117.76M.

Has Fonar Corporation ever had a stock split?

Fonar Corporation had 2 splits and the recent split was on Apr 17, 2007.

Fonar Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Timothy R. Damadian CEO
NASDAQ (CM) Exchange
344437405 CUSIP
US Country
533 Employees
18 Mar 1999 Last Dividend
17 Apr 2007 Last Split
1 Jan 1987 IPO Date

Overview

FONAR Corporation, established in 1970 and headquartered in Melville, New York, plays a pivotal role in the medical technology landscape with its innovative efforts in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners. These advanced diagnostic tools are crucial for the detection and diagnosis of human diseases, predominantly within the United States. The company distinguishes itself in the healthcare sector through its operation in two primary segments: Medical Equipment, and Physician Management and Diagnostic Services. By focusing on these areas, FONAR not only enhances the capabilities of MRI technology but also improves the efficiency and effectiveness of medical diagnostic services. FONAR's approach to healthcare solutions vividly demonstrates its commitment to improving patient care and the diagnostic process.

Products and Services

Upright MRI Scanner:

FONAR's standout product, the Upright MRI scanner, revolutionizes patient experience and diagnostic accuracy by enabling scanning in various weight-bearing positions, including standing, sitting, bending, or lying down. This innovative approach allows for the observation of physiological conditions under natural states of pressure and stress, potentially leading to more accurate diagnoses in certain clinical scenarios.

Non-medical Management Services:

Alongside its technological advancements in MRI scanners, FONAR extends its offerings to include comprehensive non-medical management services. These services encompass administrative support, billing, and collections; credentialing; contract negotiations; compliance consulting; purchasing of IT services; recruitment, training, and supervision of non-medical personnel; medical record storage; provision of office space and equipment; maintenance services; accounting; compliance assistance; and marketing strategies. This suite of services is designed to optimize the operational aspects of diagnostic imaging facilities, thereby enhancing their overall efficiency and focus on patient care.

In addition to its product and service offerings, FONAR owns and operates several diagnostic imaging facilities in Florida and manages MRI scanning facilities, expanding its influence and capabilities within the healthcare industry. The company targets a diverse client base, from private diagnostic imaging centers to hospital outpatient imaging facilities, marking its presence as a significant player in the realm of medical imaging and diagnostics.

Contact Information

Address: 110 Marcus Drive
Phone: 631 694 2929